Global Cancer Drug based on CAR-T Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Drug based on CAR-T Market Size 2017-2028

2.1.2 Cancer Drug based on CAR-T Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cancer Drug based on CAR-T Segment by Type

2.2.1 Allogeneic

2.2.2 Autologous

2.3 Cancer Drug based on CAR-T Market Size by Type

2.3.1 Cancer Drug based on CAR-T Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cancer Drug based on CAR-T Market Size Market Share by Type (2017-2022)

2.4 Cancer Drug based on CAR-T Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Cancer Drug based on CAR-T Market Size by Application

2.5.1 Cancer Drug based on CAR-T Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cancer Drug based on CAR-T Market Size Market Share by Application (2017-2022)

3 Cancer Drug based on CAR-T Market Size by Player

3.1 Cancer Drug based on CAR-T Market Size Market Share by Players

3.1.1 Global Cancer Drug based on CAR-T Revenue by Players (2020-2022)

3.1.2 Global Cancer Drug based on CAR-T Revenue Market Share by Players (2020-2022)

3.2 Global Cancer Drug based on CAR-T Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cancer Drug based on CAR-T by Regions

4.1 Cancer Drug based on CAR-T Market Size by Regions (2017-2022)

4.2 Americas Cancer Drug based on CAR-T Market Size Growth (2017-2022)

4.3 APAC Cancer Drug based on CAR-T Market Size Growth (2017-2022)

4.4 Europe Cancer Drug based on CAR-T Market Size Growth (2017-2022)

4.5 Middle East & Africa Cancer Drug based on CAR-T Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cancer Drug based on CAR-T Market Size by Country (2017-2022)

5.2 Americas Cancer Drug based on CAR-T Market Size by Type (2017-2022)

5.3 Americas Cancer Drug based on CAR-T Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Drug based on CAR-T Market Size by Region (2017-2022)

6.2 APAC Cancer Drug based on CAR-T Market Size by Type (2017-2022)

6.3 APAC Cancer Drug based on CAR-T Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cancer Drug based on CAR-T by Country (2017-2022)

7.2 Europe Cancer Drug based on CAR-T Market Size by Type (2017-2022)

7.3 Europe Cancer Drug based on CAR-T Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Drug based on CAR-T by Region (2017-2022)

8.2 Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2017-2022)

8.3 Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cancer Drug based on CAR-T Market Forecast

10.1 Global Cancer Drug based on CAR-T Forecast by Regions (2023-2028)

10.1.1 Global Cancer Drug based on CAR-T Forecast by Regions (2023-2028)

10.1.2 Americas Cancer Drug based on CAR-T Forecast

10.1.3 APAC Cancer Drug based on CAR-T Forecast

10.1.4 Europe Cancer Drug based on CAR-T Forecast

10.1.5 Middle East & Africa Cancer Drug based on CAR-T Forecast

10.2 Americas Cancer Drug based on CAR-T Forecast by Country (2023-2028)

10.2.1 United States Cancer Drug based on CAR-T Market Forecast

10.2.2 Canada Cancer Drug based on CAR-T Market Forecast

10.2.3 Mexico Cancer Drug based on CAR-T Market Forecast

10.2.4 Brazil Cancer Drug based on CAR-T Market Forecast

10.3 APAC Cancer Drug based on CAR-T Forecast by Region (2023-2028)

10.3.1 China Cancer Drug based on CAR-T Market Forecast

10.3.2 Japan Cancer Drug based on CAR-T Market Forecast

10.3.3 Korea Cancer Drug based on CAR-T Market Forecast

10.3.4 Southeast Asia Cancer Drug based on CAR-T Market Forecast

10.3.5 India Cancer Drug based on CAR-T Market Forecast

10.3.6 Australia Cancer Drug based on CAR-T Market Forecast

10.4 Europe Cancer Drug based on CAR-T Forecast by Country (2023-2028)

10.4.1 Germany Cancer Drug based on CAR-T Market Forecast

10.4.2 France Cancer Drug based on CAR-T Market Forecast

10.4.3 UK Cancer Drug based on CAR-T Market Forecast

10.4.4 Italy Cancer Drug based on CAR-T Market Forecast

10.4.5 Russia Cancer Drug based on CAR-T Market Forecast

10.5 Middle East & Africa Cancer Drug based on CAR-T Forecast by Region (2023-2028)

10.5.1 Egypt Cancer Drug based on CAR-T Market Forecast

10.5.2 South Africa Cancer Drug based on CAR-T Market Forecast

10.5.3 Israel Cancer Drug based on CAR-T Market Forecast

10.5.4 Turkey Cancer Drug based on CAR-T Market Forecast

10.5.5 GCC Countries Cancer Drug based on CAR-T Market Forecast

10.6 Global Cancer Drug based on CAR-T Forecast by Type (2023-2028)

10.7 Global Cancer Drug based on CAR-T Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Fosun Kite Biotechnology

11.1.1 Fosun Kite Biotechnology Company Information

11.1.2 Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Offered

11.1.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Fosun Kite Biotechnology Main Business Overview

11.1.5 Fosun Kite Biotechnology Latest Developments

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Information

11.2.2 Gilead Sciences Cancer Drug based on CAR-T Product Offered

11.2.3 Gilead Sciences Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Gilead Sciences Main Business Overview

11.2.5 Gilead Sciences Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Cancer Drug based on CAR-T Product Offered

11.3.3 Novartis Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Information

11.4.2 Bristol-Myers Squibb Cancer Drug based on CAR-T Product Offered

11.4.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bristol-Myers Squibb Main Business Overview

11.4.5 Bristol-Myers Squibb Latest Developments

12 Research Findings and Conclusion

Table 1. Cancer Drug based on CAR-T Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Allogeneic

Table 3. Major Players of Autologous

Table 4. Cancer Drug based on CAR-T Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Cancer Drug based on CAR-T Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Cancer Drug based on CAR-T Market Size Market Share by Type (2017-2022)

Table 7. Cancer Drug based on CAR-T Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cancer Drug based on CAR-T Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Cancer Drug based on CAR-T Market Size Market Share by Application (2017-2022)

Table 10. Global Cancer Drug based on CAR-T Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Cancer Drug based on CAR-T Revenue Market Share by Player (2020-2022)

Table 12. Cancer Drug based on CAR-T Key Players Head office and Products Offered

Table 13. Cancer Drug based on CAR-T Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Cancer Drug based on CAR-T Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Cancer Drug based on CAR-T Market Size Market Share by Regions (2017-2022)

Table 18. Americas Cancer Drug based on CAR-T Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Cancer Drug based on CAR-T Market Size Market Share by Country (2017-2022)

Table 20. Americas Cancer Drug based on CAR-T Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Cancer Drug based on CAR-T Market Size Market Share by Type (2017-2022)

Table 22. Americas Cancer Drug based on CAR-T Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Cancer Drug based on CAR-T Market Size Market Share by Application (2017-2022)

Table 24. APAC Cancer Drug based on CAR-T Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Cancer Drug based on CAR-T Market Size Market Share by Region (2017-2022)

Table 26. APAC Cancer Drug based on CAR-T Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Cancer Drug based on CAR-T Market Size Market Share by Type (2017-2022)

Table 28. APAC Cancer Drug based on CAR-T Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Cancer Drug based on CAR-T Market Size Market Share by Application (2017-2022)

Table 30. Europe Cancer Drug based on CAR-T Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Cancer Drug based on CAR-T Market Size Market Share by Country (2017-2022)

Table 32. Europe Cancer Drug based on CAR-T Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Cancer Drug based on CAR-T Market Size Market Share by Type (2017-2022)

Table 34. Europe Cancer Drug based on CAR-T Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Cancer Drug based on CAR-T Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Cancer Drug based on CAR-T Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Cancer Drug based on CAR-T

Table 43. Key Market Challenges & Risks of Cancer Drug based on CAR-T

Table 44. Key Industry Trends of Cancer Drug based on CAR-T

Table 45. Global Cancer Drug based on CAR-T Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Cancer Drug based on CAR-T Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Cancer Drug based on CAR-T Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Cancer Drug based on CAR-T Market Size Market Share Forecast by Application (2023-2028)

Table 51. Fosun Kite Biotechnology Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors

Table 52. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Offered

Table 53. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Fosun Kite Biotechnology Main Business

Table 55. Fosun Kite Biotechnology Latest Developments

Table 56. Gilead Sciences Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors

Table 57. Gilead Sciences Cancer Drug based on CAR-T Product Offered

Table 58. Gilead Sciences Main Business

Table 59. Gilead Sciences Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Gilead Sciences Latest Developments

Table 61. Novartis Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors

Table 62. Novartis Cancer Drug based on CAR-T Product Offered

Table 63. Novartis Main Business

Table 64. Novartis Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Novartis Latest Developments

Table 66. Bristol-Myers Squibb Details, Company Type, Cancer Drug based on CAR-T Area Served and Its Competitors

Table 67. Bristol-Myers Squibb Cancer Drug based on CAR-T Product Offered

Table 68. Bristol-Myers Squibb Main Business

Table 69. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. Cancer Drug based on CAR-T Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cancer Drug based on CAR-T Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cancer Drug based on CAR-T Market Size Market Share by Type in 2021

Figure 7. Cancer Drug based on CAR-T in Hospital

Figure 8. Global Cancer Drug based on CAR-T Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Cancer Drug based on CAR-T in Pharmacy

Figure 10. Global Cancer Drug based on CAR-T Market: Pharmacy (2017-2022) & ($ Millions)

Figure 11. Cancer Drug based on CAR-T in Other

Figure 12. Global Cancer Drug based on CAR-T Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Cancer Drug based on CAR-T Market Size Market Share by Application in 2021

Figure 14. Global Cancer Drug based on CAR-T Revenue Market Share by Player in 2021

Figure 15. Global Cancer Drug based on CAR-T Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Cancer Drug based on CAR-T Market Size 2017-2022 ($ Millions)

Figure 17. APAC Cancer Drug based on CAR-T Market Size 2017-2022 ($ Millions)

Figure 18. Europe Cancer Drug based on CAR-T Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Cancer Drug based on CAR-T Market Size 2017-2022 ($ Millions)

Figure 20. Americas Cancer Drug based on CAR-T Value Market Share by Country in 2021

Figure 21. Americas Cancer Drug based on CAR-T Consumption Market Share by Type in 2021

Figure 22. Americas Cancer Drug based on CAR-T Market Size Market Share by Application in 2021

Figure 23. United States Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Cancer Drug based on CAR-T Market Size Market Share by Region in 2021

Figure 28. APAC Cancer Drug based on CAR-T Market Size Market Share by Application in 2021

Figure 29. China Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Cancer Drug based on CAR-T Market Size Market Share by Country in 2021

Figure 36. Europe Cancer Drug based on CAR-T Market Size Market Share by Type in 2021

Figure 37. Europe Cancer Drug based on CAR-T Market Size Market Share by Application in 2021

Figure 38. Germany Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Cancer Drug based on CAR-T Market Size Market Share by Application in 2021

Figure 46. Egypt Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Cancer Drug based on CAR-T Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 52. APAC Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 53. Europe Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 55. United States Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 56. Canada Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 59. China Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 60. Japan Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 61. Korea Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 63. India Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 64. Australia Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 65. Germany Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 66. France Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 67. UK Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 68. Italy Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 69. Russia Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 70. Spain Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 73. Israel Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Cancer Drug based on CAR-T Market Size 2023-2028 ($ Millions)